[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX9205808A - AN INJECTABLE VETERINARY COMPOSITION FREE OF HARMFUL SIDE EFFECTS AND A PROCESS FOR ITS PREPARATION. - Google Patents

AN INJECTABLE VETERINARY COMPOSITION FREE OF HARMFUL SIDE EFFECTS AND A PROCESS FOR ITS PREPARATION.

Info

Publication number
MX9205808A
MX9205808A MX9205808A MX9205808A MX9205808A MX 9205808 A MX9205808 A MX 9205808A MX 9205808 A MX9205808 A MX 9205808A MX 9205808 A MX9205808 A MX 9205808A MX 9205808 A MX9205808 A MX 9205808A
Authority
MX
Mexico
Prior art keywords
side effects
preparation
veterinary composition
harmful side
composition free
Prior art date
Application number
MX9205808A
Other languages
Spanish (es)
Inventor
Hedvig Szauder
Margit Nagy
Attila Nagy
Laszlo Puskas
Maria Kovacs
Antal Mosonyi
Katalin Sumeg
Magdolna Gora
Janos Egri
Katalin Baranek
Theodora Marian
Iidiko Clementis
Original Assignee
Egis Gyogyszergyaer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyaer filed Critical Egis Gyogyszergyaer
Publication of MX9205808A publication Critical patent/MX9205808A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención se refiere a una composición veterinaria inyectable que esta libre de efectos secundarios tóxicos, en la cual la sustancia activa consiste de 2,4-diamino-5-/3,4,5-trimetoxibencil/-pirimidina y 3-4-aminofenilsulfonamido/-5metilisoxazol, y un proceso para la preparación de la composición. Es bien conocido que la acción de las sulfonamidas es potenciada por la 2,4-diamino-5-/3,4,5-trimetoxibencil/-pirimidina/t rimetoprima/(especificación de patente británica No. 1 176 395).The invention relates to an injectable veterinary composition that is free from toxic side effects, in which the active substance consists of 2,4-diamino-5- / 3,4,5-trimethoxybenzyl / -pyrimidine and 3-4-aminophenylsulfonamido. / -5methylisoxazole, and a process for preparing the composition. It is well known that the action of sulfonamides is enhanced by 2,4-diamino-5- / 3,4,5-trimethoxybenzyl / -pyrimidine / t rimethoprim / (British Patent Specification No. 1 176 395).

MX9205808A 1991-10-11 1992-10-09 AN INJECTABLE VETERINARY COMPOSITION FREE OF HARMFUL SIDE EFFECTS AND A PROCESS FOR ITS PREPARATION. MX9205808A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU322291A HU210693B (en) 1991-10-11 1991-10-11 Process for producing pharmaceutical compositions for injections without tissue damages, containing sulfamethoxazol and trimetoprime

Publications (1)

Publication Number Publication Date
MX9205808A true MX9205808A (en) 1993-07-01

Family

ID=10963176

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9205808A MX9205808A (en) 1991-10-11 1992-10-09 AN INJECTABLE VETERINARY COMPOSITION FREE OF HARMFUL SIDE EFFECTS AND A PROCESS FOR ITS PREPARATION.

Country Status (11)

Country Link
CN (1) CN1035468C (en)
BR (1) BR9203951A (en)
CZ (1) CZ309392A3 (en)
GB (1) GB2260268B (en)
HU (1) HU210693B (en)
LT (1) LT3063B (en)
MX (1) MX9205808A (en)
RO (1) RO112241B1 (en)
RU (1) RU2059408C1 (en)
SK (1) SK309392A3 (en)
YU (1) YU91492A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7201928B1 (en) 1999-09-21 2007-04-10 Rutgers, The State University Of New Jersey Extracts of orange peel for prevention and treatment of cancer
RU2603623C2 (en) 2014-06-06 2016-11-27 Олег Ильич Эпштейн Veterinary composition and method for improving viability of animals, stimulation of body weight gain in mammals and birds, increasing efficiency of immunising, preventing and/or treating infectious diseases (versions)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2538678A1 (en) 1975-08-30 1977-03-03 Boehringer Mannheim Gmbh Injectable solns. contg. trimethoprim and sulphamethoxazole - of physiologically tolerable pH and contg. only small amts. of organic solvents
US4303643A (en) * 1979-07-05 1981-12-01 Pfizer Inc. Sulfonamide compositions
ATE3750T1 (en) * 1979-07-05 1983-06-15 Pfizer Inc. SULFONAMIDE SOLUTIONS.
HU180740B (en) 1979-11-27 1983-04-29 Egyt Gyogyszervegyeszeti Gyar Process for producing sulfonamide-containing,injectable pharmaceutical composition of prolongated activity
JPS57109713A (en) * 1980-12-26 1982-07-08 Shionogi & Co Ltd Pharmaceutical preparation of combined agent of sulfamethoxazole and trimethoprim for medication through celom

Also Published As

Publication number Publication date
HU913222D0 (en) 1992-01-28
LT3063B (en) 1994-10-25
GB2260268A (en) 1993-04-14
GB9221114D0 (en) 1992-11-18
SK309392A3 (en) 1995-03-08
CN1035468C (en) 1997-07-23
BR9203951A (en) 1993-04-27
CZ309392A3 (en) 1994-02-16
CN1071576A (en) 1993-05-05
RU2059408C1 (en) 1996-05-10
LTIP165A (en) 1994-03-25
YU91492A (en) 1995-12-04
HU210693B (en) 1995-06-28
GB2260268B (en) 1995-06-07
RO112241B1 (en) 1997-07-30
HUT64839A (en) 1994-03-28

Similar Documents

Publication Publication Date Title
DE69133576D1 (en) Process for the preparation of enantiomerically pure beta-D-dioxolane nucleosides
CO4970769A1 (en) INSOLUBLE INSULIN COMPOSITIONS DO INSULIN FOR THE CONTROL OF GLUCOSE IN THE BLOOD AND THE PROCESS FOR THE PREPARATION OF THE COMPOSITIONS
AR012671A1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OR PROPHYLAXIS OF THE CONSTIPATION, THE USES OF SUCH COMPOSITIONS AND THE PROCESSES TO PREPARE THEM
ES526102A0 (en) IMPROVEMENTS INTRODUCED IN THE PURPOSE OF THE MAIN INVENTION PATENT N 518.044 BY: IMPROVEMENTS IN THE MANUFACTURE OF AMMUNITION, PREFERABLY FOR EMPLOYMENT AGAINST COVERED OBJECTIVES
ATE83374T1 (en) NEW GALENIC FORM OF FENOFIBRATE.
BR9007728A (en) COMPOSITION OF SOLID CALCIUM HYPOCLORITE, AND PROCESS TO FORM Aqueous CALCIUM HYPOCLORITE SOLUTION
AR240332A1 (en) COMPOSITIONS TO FACILITATE THE EXTRACTION OF MOLDED ARTICLES FROM POLIABLES, POLIABLES COMPOSITIONS THAT CONTAIN THEM.
MX9203396A (en) MOMETASONE FUROATE MONOHYDRATE, PROCESS TO PRODUCE IT AND PHARMACEUTICAL COMPOSITIONS.
ATE231839T1 (en) POLYAROMATIC ANTIVIRAL COMPOSITIONS
AR031520A1 (en) AN INHIBITOR COMPOSITE OF ASPARTILO PROTEASA, A COMPOSITION THAT INCLUDES IT AND A METHOD TO TREAT A PATIENT WITH SUCH COMPOSITION
SV1994000071A (en) PROCEDURE OF A STAGE FOR THE MANUFACTURE OF 3-CHINOLONCARBOXYLIC ACID DERIVATIVES, REF. LE A 29 572-SV.
ES2061688T3 (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE A CALCITONINE AND A GLICIRRICINATE AS IMPROVER OF ABSORPTION.
IT1265101B1 (en) DERIVATIVES OF 2-AMINO-4-PHENYL-4-BUTYRIC BONE ACID
IT8123940A0 (en) DERIVATIVES OF S-ADENOSYLMETHIONINE, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS WHICH CONTAIN THEM AS THE ACTIVE INGREDIENT.
PT94226A (en) PREPARATION PROCEDURE OF 1,2-DIOXETHANES THAT PRODUCE QUIMIOLUMINESCENCE BY DOUBLE ACTIVATION
SE8303696L (en) PHARMACOLOGICAL COMPOSITIONS
ES2032339T3 (en) PROCEDURE FOR PREPARING NEW INDOLYLPIPERIDINE COMPOUNDS.
DE3166111D1 (en) Pharmaceutical composition for healing inflammatory and/or degenerative and/or atrophic mucous membranes
AR002247A1 (en) ELEUTEROBINA AND ANALOGS OF THE SAME AND COMPOSITIONS THAT INCLUDE THEM.
MX9205808A (en) AN INJECTABLE VETERINARY COMPOSITION FREE OF HARMFUL SIDE EFFECTS AND A PROCESS FOR ITS PREPARATION.
IT8323058A0 (en) BIOLOGICALLY ACTIVE 2,5-PIPERAZINDION DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
MX172107B (en) PROCEDURE FOR DISINFECTION OF MASSES FOR MEDICINAL EMPTYING
GT199900062A (en) EFFERVESCENT PREPARATIONS.
ATE190498T1 (en) STABLE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN HYBRID ALPHA INTERFERON
DK0469064T3 (en) Use of C-20 to C-26 aliphatic alcohols for the manufacture of a medicament for the treatment of viral infections